Immunicum: Patent application related to Immunicum’s therapeutic cancer vaccine SUBCUVAX to be granted in the US 19 December 2014 Read more
Immunicum: Patent application related to Immunicum's therapeutic cancer vaccine SUBCUVAX to be granted in the US 19 December 2014 Read more
Immunicum: The patent application relating to activation of Immunicum’s COMBIG-cells for therapeutic cancer vaccination will be granted in the US 15 December 2014 Read more
Immunicum: The patent application relating to activation of Immunicum's COMBIG-cells for therapeutic cancer vaccination will be granted in the US 15 December 2014 Read more
Immunicum reports continued promising survival data for INTUVAX-treated renal cancer patients 3 December 2014 Read more
Immunicum presents safety and survival data from a clinical phase I/II study with INTUVAX in patients with liver cancer 3 December 2014 Read more
Immunicum reports continued promising survival data for INTUVAX-treated renal cancer patients 3 December 2014 Read more
Immunicum presents safety and survival data from a clinical phase I/II study with INTUVAX in patients with liver cancer 3 December 2014 Read more
Immunicum acquires patent for oncolytic therapy and further development of SUBCUVAX 27 October 2014 Read more
Immunicum acquires patent for oncolytic therapy and further development of SUBCUVAX 27 October 2014 Read more
Immunicum presents updated survival data for INTUVAX-treated renal cancer patients 12 September 2014 Read more
Immunicum presents updated survival data for INTUVAX-treated renal cancer patients 12 September 2014 Read more
Immunicum reports preliminary regression data after add-on therapy with tyrosine kinase inhibitors and continued compelling survival data from the formally completed phase I/II-study in renal cell carcinoma 21 May 2014 Read more
Immunicum reports preliminary regression data after add-on therapy with tyrosine kinase inhibitors and continued compelling survival data from the formally completed phase I/II-study in renal cell ... 21 May 2014 Read more
Date for Immunicum’s interim report for the period July 2013 – March 2014 changed 15 April 2014 Read more
Date for Immunicum's interim report for the period July 2013 - March 2014 changed 15 April 2014 Read more
Immunicum has completed a private placement and resolved on a fully underwritten rights issue 2 April 2014 Read more
Immunicum has completed a private placement and resolved on a fully underwritten rights issue 2 April 2014 Read more
Immunicum submits the final report for its phase I/II trial in metastatic renal cell carcinoma showing positive safety data and promising survival data 31 March 2014 Read more
Immunicum submits the final report for its phase I/II trial in metastatic renal cell carcinoma showing positive safety data and promising survival data 31 March 2014 Read more
Immunicum’s abstract with data from a kidney cancer study has been approved for presentation at the 2014 ASCO Annual Meeting in Chicago 27 March 2014 Read more
Immunicum's abstract with data from a kidney cancer study has been approved for presentation at the 2014 ASCO Annual Meeting in Chicago 27 March 2014 Read more
Immunicum reports promising preclinical results for its CD70 technology in adoptive immunotherapy 6 March 2014 Read more
Immunicum reports promising preclinical results for its CD70 technology in adoptive immunotherapy 6 March 2014 Read more
